ORGANOGENESIS HOLDINGS INC. Investing Cash Flow
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Investing Cash Flow of -$4.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$1.10M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.15M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$4.65M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.23M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2025 was -$14.15M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2024 was -$10.03M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2023 was -$24.36M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2022 was -$33.90M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.25M 10-Q · filed 2026-08-06 | -$8.90M derived: sum of 3 quarters · filed 2026-08-06 | -$11.13M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$3.15M 10-Q · filed 2026-05-07 | -$7.80M derived: sum of 2 quarters · filed 2026-05-07 | -$10.03M derived: sum of 3 quarters · filed 2026-05-07 | -$13.67M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$6.89M derived: sum of 2 quarters · filed 2026-02-26 | -$10.53M derived: sum of 3 quarters · filed 2026-08-06 | -$14.15M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.87M derived: sum of 2 quarters · filed 2026-08-06 | -$9.50M 10-Q · filed 2025-11-06 | -$12.86M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$3.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.26M 10-Q · filed 2026-08-06 | -$10.63M derived: sum of 3 quarters · filed 2026-08-06 | -$13.19M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$3.63M 10-Q · filed 2026-05-07 | -$6.99M derived: sum of 2 quarters · filed 2026-05-07 | -$9.56M derived: sum of 3 quarters · filed 2026-05-07 | -$11.44M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.93M derived: sum of 2 quarters · filed 2026-02-26 | -$7.81M derived: sum of 3 quarters · filed 2026-02-26 | -$10.03M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.45M derived: sum of 2 quarters · filed 2025-11-06 | -$6.67M 10-Q · filed 2025-11-06 | -$9.99M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.10M 10-Q · filed 2025-08-07 | -$7.43M derived: sum of 3 quarters · filed 2026-02-26 | -$13.40M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$2.22M 10-Q · filed 2025-05-08 | -$5.55M derived: sum of 2 quarters · filed 2026-02-26 | -$11.53M derived: sum of 3 quarters · filed 2026-02-26 | -$19.02M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.30M derived: sum of 2 quarters · filed 2026-02-26 | -$16.80M derived: sum of 3 quarters · filed 2026-02-26 | -$24.36M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$5.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$13.48M derived: sum of 2 quarters · filed 2024-11-12 | -$21.04M 10-Q · filed 2024-11-12 | -$31.70M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | -$7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$15.06M 10-Q · filed 2024-08-08 | -$25.72M derived: sum of 3 quarters · filed 2025-02-27 | -$36.12M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$7.56M 10-Q · filed 2024-05-09 | -$18.22M derived: sum of 2 quarters · filed 2025-02-27 | -$28.62M derived: sum of 3 quarters · filed 2025-02-27 | -$34.79M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -$10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$21.06M derived: sum of 2 quarters · filed 2025-02-27 | -$27.23M derived: sum of 3 quarters · filed 2025-02-27 | -$33.90M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$16.57M derived: sum of 2 quarters · filed 2023-11-09 | -$23.24M 10-Q · filed 2023-11-09 | -$28.47M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | -$6.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$12.84M 10-Q · filed 2023-08-09 | -$18.07M derived: sum of 3 quarters · filed 2024-02-29 | -$34.77M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$6.67M 10-Q · filed 2023-05-10 | -$11.90M derived: sum of 2 quarters · filed 2024-02-29 | -$28.60M derived: sum of 3 quarters · filed 2024-02-29 | -$32.94M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | -$5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$21.93M derived: sum of 2 quarters · filed 2024-02-29 | -$26.26M derived: sum of 3 quarters · filed 2024-02-29 | -$31.22M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$16.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$21.04M derived: sum of 2 quarters · filed 2022-11-09 | -$25.99M 10-Q · filed 2022-11-09 | -$31.41M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | -$4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$9.29M 10-Q · filed 2022-08-09 | -$14.71M derived: sum of 3 quarters · filed 2023-03-01 | -$26.67M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | -$4.96M 10-Q · filed 2022-05-10 | -$4.78M 10-Q · filed 2021-05-11 | -$10.38M derived: sum of 2 quarters · filed 2023-03-01 | -$22.34M derived: sum of 3 quarters · filed 2023-03-01 | -$24.21M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$17.38M derived: sum of 2 quarters · filed 2023-03-01 | -$19.25M derived: sum of 3 quarters · filed 2023-03-01 | -$23.50M 10-K · filed 2023-03-01 | -$24.83M 10-K · filed 2021-03-16 | ||
| 2020-09-30 | -$11.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$13.84M derived: sum of 2 quarters · filed 2021-11-09 | -$18.08M 10-Q · filed 2021-11-09 | -$16.35M 10-Q · filed 2020-11-09 | -$21.54M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$6.12M 10-Q · filed 2021-08-09 | -$9.58M derived: sum of 3 quarters · filed 2022-03-01 | -$10.85M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$4.24M 10-Q · filed 2021-05-11 | -$7.70M derived: sum of 2 quarters · filed 2022-03-01 | -$8.98M derived: sum of 3 quarters · filed 2022-03-01 | -$10.16M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$4.73M derived: sum of 2 quarters · filed 2022-03-01 | -$5.92M derived: sum of 3 quarters · filed 2022-03-01 | -$6.23M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$2.46M derived: sum of 2 quarters · filed 2020-11-09 | -$2.78M 10-Q · filed 2020-11-09 | -$3.14M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.50M 10-Q · filed 2020-08-10 | -$1.86M derived: sum of 3 quarters · filed 2021-03-16 | -$2.80M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-03-31 | -$317.00K 10-Q · filed 2020-05-11 | -$679.00K derived: sum of 2 quarters · filed 2021-03-16 | -$1.62M derived: sum of 3 quarters · filed 2021-03-16 | -$2.11M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2018-12-31 | -$362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$1.30M derived: sum of 2 quarters · filed 2021-03-16 | -$1.79M derived: sum of 3 quarters · filed 2021-03-16 | -$1.86M 10-K · filed 2021-03-16 | |||
| 2018-09-30 | -$937.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.43M derived: sum of 2 quarters · filed 2019-11-12 | -$1.49M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$492.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$557.00K 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | -$65.00K 10-Q · filed 2019-05-10 | ||||||
| 2017-12-31 | -$14.87M 10-K · filed 2020-03-09 | ||||||
| 2017-06-30 | -$375.00K 10-Q · filed 2017-08-11 | ||||||
| 2016-12-31 | -$1.25M 10-K · filed 2019-03-18 | -$310.00M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |